Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHD
María Queralt Salas(Canary Institute of Cancer Research), Auro Viswabandya(Princess Margaret Cancer Centre), Shruti Prem(University Health Network), David Loach(University Health Network), Rajat Kumar(University Health Network), Arjun Law(University of Toronto), Eshetu G. Atenafu(Princess Margaret Cancer Centre), Fotios V. Michelis(Princess Margaret Cancer Centre), Jonas Mattsson(University Health Network), Dennis Dong Hwan Kim(University Health Network), Zeyad Al‐Shaibani(University Health Network), Wilson Lam(Princess Margaret Cancer Centre), Jeffrey H. Lipton(Princess Margaret Cancer Centre)
Cited by 59
Related Papers
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2010|1k
BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia
|Cancer Cell|2014|366
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
|Leukemia|2008|354